Panel backs Pfizer drug for juvenile arthritis

Thu, 30 Nov 2006 05:11 AM EST

... GAITHERSBURG, Maryland (Reuters) - Pfizer Inc.'s pain reliever Celebrex should be approved for treating rheumatoid arthritis in children, a U.S. advisory panel said in a 15-1 vote on Wednesday despite concerns about the drug's long-term safety. ...